How to Help Your Patients Find Northera in Stock: A Provider's Guide

How to Help Your Patients Find Northera in Stock: A Provider's Guide

Patients with neurogenic orthostatic hypotension (nOH) depend on Droxidopa (Northera) to manage a condition that directly impacts their ability to stand safely and function independently. When they can't fill their prescription, the consequences are real: dizziness, falls, fractures, and emergency department visits.

As a prescriber, you're in a unique position to help patients navigate the practical challenges of filling a specialty prescription like Northera. This guide provides concrete steps your team can take to improve treatment continuity.

Current Availability Landscape

Droxidopa is not in a formal FDA shortage. However, practical availability remains inconsistent:

• Retail chain pharmacies frequently do not stock Droxidopa due to low demand
• Generic Droxidopa (available since 2021, 11+ manufacturers) is more accessible than brand, but still requires proactive pharmacy sourcing
• Brand-name Northera is often distributed through specialty pharmacy channels
• Insurance barriers (prior authorization, step therapy) delay initial fills and sometimes refills

Understanding this landscape helps you set appropriate expectations with patients and take preemptive action during the prescribing process.

Why Patients Can't Find It

When patients report "my pharmacy doesn't have Northera," the underlying cause is usually one of these:

1. The pharmacy doesn't routinely stock it — Droxidopa is a low-volume medication at most retail locations. The pharmacy may be willing to order it but didn't have it on hand
2. Insurance hasn't authorized it yet — prior authorization can take 3-7 business days, during which the pharmacy may show the prescription as "pending"
3. The patient asked for brand only — brand-name Northera may only be available through specialty pharmacies. Generic Droxidopa is more widely distributed
4. Wholesaler backorder at that specific pharmacy — temporary, localized stock issues that don't represent a broader shortage

What Providers Can Do: 5 Steps

Step 1: Write for Generic Unless Clinically Necessary

Prescribing generic Droxidopa rather than brand-name Northera significantly increases the likelihood that a pharmacy can fill the prescription. All approved generics are AB-rated (therapeutically equivalent). Reserve "Dispense as Written" for cases where a patient has documented intolerance to a specific generic formulation.

Step 2: Submit Prior Authorization Proactively

Don't wait for the pharmacy to trigger a PA rejection. When you decide to prescribe Droxidopa:

• Submit the prior authorization before or simultaneously with sending the prescription to the pharmacy
• Include: documented nOH diagnosis, orthostatic blood pressure readings (≥20 mmHg systolic or ≥10 mmHg diastolic drop), previous medication trials (Midodrine, if step therapy applies), and clinical rationale
• Designate a team member to follow up on PA status within 48 hours

Many denials occur because of incomplete documentation. A thorough initial submission reduces delays.

Step 3: Direct Patients to the Right Pharmacy

Rather than sending the prescription to the patient's usual retail pharmacy (which may not stock Droxidopa), consider these options:

• Specialty pharmacies that serve neurological patients — most reliably stock Droxidopa
• Independent pharmacies — often more willing to order specialty medications
• Medfinder for Providers — a free tool that shows which pharmacies near your patient currently have Droxidopa in stock. Share this resource with your care team

Step 4: Educate Patients About Cost-Saving Options

Cost is a major barrier to adherence. Equip patients with:

• Lundbeck Copay Assistance Program: Eligible commercially insured patients pay as little as $10/month for brand Northera (activatethecard.com/7773)
• Discount cards: GoodRx, SingleCare, and similar services can reduce generic Droxidopa to $44-$120/month vs. $3,100+ retail
• Patient assistance programs: Prescription Hope offers Droxidopa for $70/month; NeedyMeds and RxAssist list additional options

For a comprehensive cost guide, direct patients to How to Save Money on Northera.

Step 5: Have a Backup Plan for Gaps

If a patient faces a temporary gap in Droxidopa supply, document your contingency plan:

• Midodrine (2.5-10 mg TID) — widely available, affordable ($10-$30/month generic), can provide interim blood pressure support
• Fludrocortisone (0.1-0.2 mg daily) — volume expander, useful adjunct but monitor for edema and hypokalemia
• Non-pharmacologic measures: Compression garments, increased salt and fluid intake, slow positional changes

Having a documented backup plan prevents gaps in care and reduces patient anxiety about refill challenges.

Alternatives to Consider

For patients who cannot consistently access Droxidopa or who don't respond adequately, evidence-based alternatives include:

• Midodrine: Alpha-1 agonist, FDA-approved for orthostatic hypotension, widely available generic
• Fludrocortisone: Mineralocorticoid for volume expansion, off-label for nOH
• Pyridostigmine: Acetylcholinesterase inhibitor, may raise standing BP without significantly increasing supine BP — useful when supine hypertension is a primary concern

Combination therapy (e.g., Droxidopa + Midodrine, or Droxidopa + Fludrocortisone) is sometimes necessary for refractory nOH, with careful blood pressure monitoring.

Workflow Tips for Your Practice

• Template your PA documentation: Create a standardized letter/form for Droxidopa prior authorizations that includes all commonly required elements
• Flag nOH patients in your EHR: Set medication refill reminders so your team can proactively check on authorization status before the patient runs out
• Maintain a pharmacy resource list: Keep a list of specialty pharmacies and independent pharmacies in your area that reliably stock Droxidopa
• Bookmark Medfinder for Providers: Add it to your practice's resource toolkit for real-time pharmacy stock checks
• Educate at first prescription: At the time of prescribing, brief the patient on potential pharmacy sourcing challenges and provide them with the tools (Medfinder, discount cards, copay program info) to fill independently

Final Thoughts

Your patients with nOH are managing a challenging, often debilitating condition. The last thing they need is added stress from filling a prescription. By prescribing generics, proactively handling prior authorizations, directing patients to the right pharmacies, and sharing cost-saving resources, you can dramatically improve their experience and treatment continuity.

For the patient-facing version of this information, share our article on how to find Northera in stock. For shortage updates, see our clinical shortage briefing.